abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding abrdn Life Sciences Investors changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 75 | 3 | 73 | +1 |
| Shares | 9.89M | 213.3K | 9.49M | −182.7K (−1.9%) |
| Value | $148.9M | $3.22M | $124.5M | −$21.1M (−14.5%) |
3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held abrdn Life Sciences Investors at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Raymond James Financial Inc | 238,470 | $3.13M | 0.00% |
| Wolverine Asset Management LLC | 121,463 | $1.59M | 0.03% |
| Rivernorth Capital Management, LLC | 39,814 | $522.4K | 0.03% |
| Readystate Asset Management LP | 38,592 | $506.3K | 0.02% |
| Jane Street Group, LLC | 22,098 | $289.9K | 0.00% |
| Guggenheim Capital LLC | 16,053 | $210.6K | 0.00% |
| Independent Financial Group, LLC | 13,150 | $172.5K | 0.01% |
| Kingswood Wealth Advisors, LLC | 12,211 | $160.2K | 0.01% |
| Landscape Capital Management, L.L.C. | 11,729 | $153.9K | 0.02% |
| BankPlus Trust Department | 2,134 | $28.0K | 0.01% |
| FNY Investment Advisers, LLC | 1,600 | $20.0K | 0.01% |
| VSM Wealth Advisory, LLC | 1,374 | $18.0K | 0.01% |
| Capital A Wealth Management, LLC | 455 | $5.97K | 0.01% |
| Atlas Capital Advisors LLC | 138 | $1.81K | 0.00% |
Sold out (13)
Institutions that held abrdn Life Sciences Investors at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Cetera Investment Advisers | 171,428 | $2.59M |
| Wedbush Securities Inc | 16,273 | $245.0K |
| Wealth Enhancement Advisory Services, LLC | 15,932 | $240.3K |
| Millennium Management LLC | 13,560 | $204.5K |
| Quantedge Capital Pte Ltd | 13,220 | $199.4K |
| Twelve Points Wealth Management LLC | 11,375 | $171.5K |
| Ashton Thomas Securities, LLC | 9,817 | $148.0K |
| Jaffetilchin Investment Partners, LLC | 4,585 | $69.1K |
| Householder Group Estate & Retirement Specialist, LLC | 1,259 | $18.0K |
| IFP Advisors, Inc | 22 | $332 |
| Washington Trust Co | 10 | $148 |
| JPMorgan Chase & Co | 2 | $30 |
| International Assets Investment Management, LLC | 13,507 | – |
Not filed for Q4 2024 yet (3)
Institutions that held abrdn Life Sciences Investors at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 168,876 | $2.55M |
| Raymond James & Associates | 44,147 | $665.7K |
| WFA of San Diego, LLC | 300 | $4.52K |